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Background: Services provided by community pharmacists designed to support people using 
medicines are increasing. In England, two national services exist: Medicine Use Reviews (MUR) 
and New Medicines Service (NMS). Very few studies have been conducted seeking views of 
the public, rather than service users, on willingness to use these services or expectations of these 
services, or determined whether views align with pharmacist perceptions.
Objective: To compare the perceptions of pharmacists and the general public on medicines-
related services, particularly MUR and NMS services.
Methods: Two parallel surveys were conducted in one area of England: one involved the 
general public and was administered using a street survey, and the other was a postal survey of 
community pharmacists. Similar questionnaires were used, seeking views of services, aware-
ness, reasons for using services, and perceived benefits.
Results: Response rates were 47.2% (1,000/2,012 approached) for the public and 40.8% 
(341/836) for pharmacists. Few people had experienced a discussion in a private consultation 
room or were aware of the two formal services, although their willingness to use them was high. 
Pharmacists estimated time spent on service provision as 10 minutes for MUR and 12 minutes for 
NMS, which aligned with acceptability to both pharmacists and the public. Pharmacists underes-
timated the willingness of the public to wait for an informal discussion or to make appointments 
for formal services. Both pharmacists and the public had high expectations that services would 
be beneficial in terms of increasing knowledge and understanding, but public expectations and 
experiences of services helping to sort out problems fell well below pharmacists’ perceptions. 
People who had experienced a pharmacy service had different perceptions of pharmacists.
Conclusion: Views differed regarding why people use services and key aspects of service 
delivery. For services to improve, the pharmacy profession needs a better awareness of what 
the public, especially those with potential to benefit from services, view as acceptable and 
desirable.
Keywords: community pharmacy, public opinion, pharmacist perceptions, medicines-related 
services
Introduction
Community pharmacists are increasingly being commissioned to provide cognitive services 
to support and improve medicines use, such as the Home Medicine Review (HMR) service 
in Australia and Medication Therapy Management (MTM) services in the US. In England, 
the Medicines Use Review (MUR) service was introduced in 2005 and by 2014/15, 3.2 
million MURs were provided by 93.5% (10,916) of community pharmacies in England.1 
This service aims to improve patients’ knowledge and use of medicines and help reduce 
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medicines wastage. Changes in 2011 require that at least half 
the MURs provided must be targeted toward patients with respi-
ratory disease, those taking high-risk medicines ( nonsteroidal 
anti-inflammatory drug, anticoagulant, antiplatelet, or diuretic) 
and those recently discharged from a hospital.
An early evaluation found that 93% of pharmacists 
viewed the MUR as potentially improving patients’ use of 
medicines, including adherence and cost-effectiveness,2 
believing that patients would want pharmacists to review 
their medicines. Later in-depth work suggested that MURs 
were poorly integrated into pharmacy workflow, most being 
provided on an ad hoc basis, conducted with people using 
few medicines, in part due to dispensing pressures and target 
numbers imposed by employers.3
Most studies seeking the views of patients or pharmacists 
on the MUR service have been small scale,2,4–8 showing that 
patients seldom request an MUR, most are initiated by phar-
macists and patients feel obliged to undergo one to help the 
pharmacist. An in-depth study of MUR consultations found 
that the experience did not increase patients’ knowledge and 
it rarely affected medicine use.3 These findings echo earlier 
work showing that patients were ambivalent about receiving 
a medicines management consultation with a pharmacist, 
viewing it as providing reassurance.9
A second formal service, the New Medicines Service 
(NMS), was introduced in England in 2011, targeted toward 
patients with asthma, COPD, diabetes, hypertension, or tak-
ing an antiplatelet/anticoagulant, aiming to help reduce symp-
toms and complications of these conditions and identify any 
related issues, including the need for further information and 
support. The service involves two or three consultations, only 
the first of which should be face-to-face interaction. A total 
of 775,998 NMS were provided by 9,308 (79.7%) English 
community pharmacies in 2014/15.1 An evaluation of this 
service found that pharmacists considered it as an opportunity 
to educate and support patients, while patients were unaware 
of it, but viewed it positively once experienced.10
Studies in several countries suggest that awareness of 
medicines-related cognitive services among the general 
public is limited. In Australia and the US, both awareness 
and expectations of these services are low.11 Being wor-
ried about medicines was a potential motivating factor for 
using the Australian HMR service,12 whereas in Sweden 
people taking-up offers of pharmaceutical care services were 
“worried, vulnerable, and information-seeking”.13 Australians 
considered improving ability to manage medicines, reducing 
concerns, and increasing knowledge were further motivating 
factors for having a HMR, but their expectations that the 
review would achieve these was low.14 The Royal Pharma-
ceutical Society in the UK has highlighted the need for greater 
public awareness of pharmacy services.15
Most studies of medicines-related services provided by 
community pharmacists have obtained views of service users 
rather than the public.16–18 No work has determined views on 
people’s willingness to make appointments, how much time 
they are willing to spend discussing their medicines with a 
pharmacist, and the use of consultation rooms for medicines-
related services, although leaflets promoting services mention 
the need to book a consultation with a pharmacist.19 Moreover, 
no studies have compared the views of the public with phar-
macists’ perceptions of these English medicine services.
This study therefore aimed to obtain the perceptions 
and experiences of both pharmacists and the general public 
on medicines-related services in general and specifically 
on MUR and NMS services, and compare pharmacist and 
public perceptions.
Methods
Two surveys were conducted in parallel, one involving 
the general public and the other community pharmacists, 
between September and December 2012, following approval 
from Medway School of Pharmacy Research Ethics commit-
tee. Members of the public provided verbal consent and the 
pharmacist questionnaire contained a statement that consent 
was implied by its return.
Questionnaire development and piloting
Public questionnaire
A previously validated questionnaire seeking public views on 
pharmacy public health services20 was adapted using findings 
from focus groups seeking public views on medicines-related 
services, together with relevant literature and the team’s expe-
rience.17 It included mostly closed questions covering: use 
of pharmacies, medicines and of medicines-related services, 
awareness of services, expectations and willingness to use ser-
vices, reasons for using services and perceived benefits, as well 
as questions covering specific aspects, such as data sharing, 
appointments, and waiting times (Supplementary materials). 
Open questions sought additional reasons for using services 
and not using pharmacies to seek advice about medicines. 
Demographic data included gender, age, ethnicity, educational 
level, and postcode for assessment of deprivation status.
Pharmacist questionnaire
This was developed using findings from focus groups that 
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Pharmacist versus public views of pharmacy medicines-related services
ensuring overlap with the public questionnaire to enable 
comparisons. The questionnaire covered pharmacists’ views 
and experiences of providing medicine advisory services and 
their perceptions of the aspects included in the public ques-
tionnaire (Supplementary materials). Open-ended questions 
sought views on reasons people may use services and whether 
different services are needed. Demographic data included 
gender, years qualified, role in pharmacy, pharmacy type and 
location, and estimated MUR and NMS service delivery.
Piloting
For the public survey, 25 members of the public known 
to researchers completed the questionnaire using an 
interviewer-assisted method, recording time for completion, 
and questioning about ease of use and understanding. Five 
pharmacists known to the team, working outside the study 
area, were asked to complete and return the pharmacist ques-
tionnaire by post, with additional questions to assess the ease 
of use. Minor amendments were made to both questionnaires 
in the light of comments received.
recruitment and data collection
Public survey
This survey was conducted using interviewer-assisted comple-
tion by ten students who had received training to ensure a 
consistent approach. The questionnaires were completed 
face-to-face with members of the public recruited at high street 
locations in ten towns in one county in South East England 
(Kent). The towns were selected to include subjects from dif-
fering socioeconomic and deprivation status. A quota sampling 
method, based on 2011 census data, was used to ensure that 
the sample was representative of the county in terms of gender 
and age, with a target of 100 participants per town. Passers-by 
were approached by a researcher and invited to participate. 
Initial screening questions excluded people ,18 years of age 
and qualified or trainee health care professionals. The number 
who declined to complete the survey was recorded.
Pharmacist survey
This was administered as a postal questionnaire sent to all 
836 community pharmacies in three counties in South East 
England (Kent, Surrey, and Sussex). Nonresponders received 
a second mail and a telephone call with a further copy of the 
questionnaire, if requested.
Data analysis
Data were analyzed using SPSS v22 (IBM Corporation, 
Armonk, NY, USA). Use of medicines by the public was 
dichotomized into any or none, and frequency of pharmacy 
use was dichotomized into frequent (at least once per month) 
or infrequent (less than once a month/never). Chi-squared 
tests were used to assess differences in responses between 
pharmacists and public to similar questions and to evaluate 
the effect of medicines and pharmacy use on experiences of 
and willingness to use services. Missing data were excluded 
from analysis. Due to the large number of comparisons made, 
a P-value of ,0.001 was regarded as statistically significant. 
Free-text responses to open-ended questions were catego-
rized and quantified.
Results
response rates and demographic 
characteristics
The response rate for the public questionnaire was 47.2% 
(1,000 from 2,012 people approached) and 40.8% (341) for 
the pharmacist questionnaire after second mailing and tele-
phone reminder. The public were reasonably representative 
of the population of Kent in terms of gender, age, ethnicity, 
and deprivation status: 52.7% (526) were females, 21.8% 
(218) were aged $65 years, 712 (72.3%) were white, and 
there was an adequate distribution across five deprivation 
quintiles. Demographic details are shown in Table 1, along 
with use of pharmacies, medicines, and general health status. 
Regular pharmacy use was associated with both older age 
and regular medicines use (P,0.001).
Pharmacist respondent characteristics are shown in 
Table 2, plus self-reported estimated frequency of MUR and 
NMS provision in the previous month.
experiences of medicines-related services
The most common reasons selected by the public for using 
a pharmacy were to have a prescription dispensed (850; 
85.1%) or to buy medicines (791; 79.2%), but getting 
advice on medicines or minor health problems was also 
selected by over two thirds (664; 66.5% and 660; 66.1%, 
respectively).
Experiences of different ways of receiving medicines- 
related advice and sharing of information are shown in 
Table 3, together with willingness to accept these aspects of 
services in future. The most frequent way in which advice 
about medicines received was across the counter, with only 
28.8% (288) indicating they had received advice about medi-
cines collected in a private consultation room and only 19.4% 
(194) for a new medicine (indicating experience of the NMS). 
Only one-quarter (248; 24.9%) had experienced a review of 
































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1





of the MUR), with few having had reviews following hospital 
discharge or because they used a specific medicine. A total of 
136 respondents (13.7%) indicated that they had experienced 
receiving both advice about new medicines and review of 
all medicines in a private room.
Most pharmacists provided information on the frequency 
of providing MUR and NMS, with the former being provided 
more frequently (Table 2). The majority of the pharmacists 
providing data (275/294; 93.5%) indicated that they had 
conducted some target MURs in the past month: 258 (87.8%) 
to people taking high-risk medicines and 251 (85.4%) to 
those using respiratory medicines, but only 75 (25.5%) 
Table 1 Demographic details of public respondents





Female 526 (52.7) 51.6*
Male 473 (47.3) 48.4*
Age group (n=1,000)
,25 140 (14.0) 26.9*
25–34 140 (14.0)
35–44 170 (17.0) 51.0*
45–54 175 (17.5)
55–64 157 (15.7)
65 and over 218 (21.8) 22.1*
ethnicity (n=985)
White 712 (72.3) 93.0**
Asian 112 (11.4) 3.6**
Black 90 (9.1) 1.3**
Mixed 62 (6.3) 1.6**
Other 9 (0.9) 0.5**
Deprivation status (n=920)
1 (highest) 157 (17.1) 20.5
2 166 (18.0) 20.2
3 172 (18.7) 19.9
4 223 (24.2) 19.8
5 (lowest) 202 (22.0) 19.7
educational level (n=992) n/a
none/primary/secondary 314 (31.7)
Further education 315 (31.8)
Bachelor/higher degree 319 (32.2)
current student 44 (4.4)
employment status (n=985) n/a
Full-time employed 411 (41.7)
Part-time employed 196 (19.9)
retired 212 (21.5)
not working 166 (16.9)





Use of pharmacies (n=999) n/a
More than once a month 136 (13.6)
Once a month 373 (37.3)
Once every 2–3 months 258 (25.8)
less than every 3 months 91 (9.1)
never use/do not know 141 (14.1)
Notes: *Derived from Kent and Medway 2011 census data of population aged 
$18 years. **Derived from Kent and Medway 2011 census data of all ages.
Abbreviation: n/a, not available.
Table 2 Demographic details of pharmacist responders and 
pharmacies
Characteristic Number (%) National data derived 
from registers (%)
sex (n=338)
Female 179 (53.0) Female 40.6
Male 159 (47.0) Male 59.4
Years qualified (n=325)
#3 78 (24.0) registrants in last 3 years/
total register
18.8
4–10 116 (35.7) registrants in last 9 years/
total register
29.3
.10 131 (40.3) remaining registrants 51.9
role in pharmacy (n=340)
Manager/sole 
pharmacist 
269 (79.1) Owner/employee 76
second pharmacist 22 (6.5)
superintendent 13 (3.8)
locum 36 (10.6) locum 24
Type of pharmacy (n=340)
large chain 
($31 pharmacies)
223 (65.6) national multiple 55
Medium chain 
(11–30)
19 (5.6) Other multiple 15
small chain (2–10) 33 (9.7) chain of #4 pharmacies 29
single pharmacy 65 (19.1)













number of MUrs in the previous month (n=299)






number of nMs in the previous month (n=303)





Abbreviations: cP, community pharmacy; gP, general practitioner; n/a, not 
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Pharmacist versus public views of pharmacy medicines-related services
targeted people recently discharged from a hospital. The 
median time taken to provide a MUR was estimated at 
10 minutes (range 2–40; n=306), median time to recruit to 
the NMS was 5 minutes (range 1–20; n=298), first consul-
tation 8 minutes (1–30; n=264), and follow-up consultation 
5 minutes (1–20; n=262).
Willingness to use services
Over 90% of the public showed willingness to use services 
in future (Table 3), but the proportion favoring receiving 
advice across the counter was higher than for a private room. 
Willingness to have a discussion with a pharmacist because 
of recent hospital discharge was lower than other reasons 
for doing so, and while 94.2% (940) were willing to allow 
sharing of information with their doctor, only 78.6% (785) 
indicated their willingness to allow data sharing with the 
local National Health Service and 78.0% (779) to allow a 
pharmacist to provide telephone follow-up. For all the aspects 
of services, respondents who were frequent pharmacy users 
and those using regular medicines were significantly more 
willing to agree than those not using pharmacies or medicines 
regularly (all P,0.001).
A majority of the public (717; 71.8%) indicated their 
willingness to make an appointment for a medicines-related 
service and 72.0% (718) to wait for 10 to 15 minutes to 
see a pharmacist (Table 4). In contrast, significantly fewer 
pharmacists considered that people would be willing to 
make appointments (161; 47.2%; P,0.001) and the major-
ity (191; 56.0%) felt that people would wait no more than 
5 minutes. However, perceptions concerning discussion time 
with a pharmacist were more closely aligned, with 59.0% of 
pharmacists (193) and 47.8% (477) of the public viewing no 
more than 15 minutes as acceptable.
reasons for using pharmacy medicines-
related services
There were 167 members of the public who indicated that 
they were worried about medicines-related problems for 
Table 3 experiences of and willingness to use medicines-related services among the public
Service/aspect of service Had experience  
of MRS, n (%)
Would be prepared to use  
MRS in the future, n (%)
Yes Maybe
received advice concerning medicines just collected
in private consultation room 288 (28.8) 695 (69.6) 216 (21.6)
in quiet area of pharmacy 325 (32.5) 732 (73.3) 203 (20.3)
Across pharmacy counter 708 (70.9) 820 (82.1) 132 (13.2)
received advice concerning new medicine just collected
in private consultation room 194 (19.4) 700 (70.1) 215 (21.5)
in quiet area of pharmacy 213 (21.3) 732 (73.3) 201 (20.1)
Across pharmacy counter 510 (51.0) 801 (80.2) 146 (14.6)
had a discussion with a pharmacist:
Because recently discharged from hospital 102 (10.2) 655 (65.6) 219 (21.9)
Because were taking particular medicine 230 (23.0) 710 (71.1) 226 (22.6)
A general review in a private consultation room 248 (24.9) 685 (68.9) 233 (23.4)
given pharmacist permission to:
Telephone you to follow-up about advice already provided 111 (11.1) 544 (54.5) 235 (23.5)
share your information with local nhs 116 (11.6) 553 (55.4) 232 (23.2)
share your information with your doctor 345 (34.6) 808 (81.0) 132 (13.2)
Abbreviations: Mrs, medicines-related service; nhs, national health service.









Time waiting to talk to the pharmacist
no more than 5 minutes 191 (56.7) 196 (19.6) ,0.001
no more than 10 minutes 111 (32.9) 370 (37.1)
no more than 15 minutes 32 (9.5) 348 (34.9)
More than 15 minutes 3 (0.9) 83 (8.3)
Making an appointment to  
talk to the pharmacist 
(% indicating yes)
161 (48.1) 717 (71.8) ,0.001
Time waiting for an appointment
no more than 4 hours 47 (15.1) 137 (13.8) ,0.001
no more than 1 day 86 (27.6) 379 (37.9)
no more than 4 days 45 (14.4) 168 (16.9)
no more than 1 week 104 (33.3) 259 (26.0)
More than 1 week 30 (9.6) 52 (5.2)
Time spent talking to pharmacist
no more than 5 minutes 44 (13.5) 168 (16.7) 0.01
no more than 15 minutes 193 (59.0) 477 (47.8)
no more than 30 minutes 64 (19.6) 216 (21.6)
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 themselves or people they cared for. The most frequent cause 
for worry was side effects, cited by 78, followed by difficul-
ties in remembering dosage regimens (23), concerns over lack 
of efficacy (13), and the overall number of medicines and 
the need for these (14). Over two-thirds of respondents (690) 
indicated that they would consider going to a pharmacy for 
advice if they did experience problems with a medicine. The 
majority of the remainder (251) indicated that they would go 
to their general practitioner (GP) instead. Reasons for choos-
ing to see a GP were given as: greater GP knowledge of them 
personally, and health or illness in general (13), pharmacist 
not being able to help/change medicines (11), and expectation 
of being referred to GP by pharmacist (8).
Potential reasons for choosing to use a formal service 
(MUR or NMS) were offered to both groups (Figure 1). 
Almost all pharmacists thought the main reason for using 
one of these services would be “because the pharmacist 
asked” (94.9%), which was selected by proportionately fewer 
members of the public (68.7%). Significantly fewer pharma-
cists (57.5%) than members of the public (76.0%) thought 
people would use a service “because they had problems with 
their medicines.” “Wanting to help the pharmacist out” was 
selected as a reason by 53.2% of the public, compared with 
22.6% of pharmacists.
While most (274; 80.4%) pharmacist respondents con-
sidered that patients needed medicines advisory services, 
only 186 (55.2%) felt they were wanted. Sixty pharma-
cists (17.6%) thought that different or additional services 
or changes to the existing formal services were needed. 
Among these, eight suggested services needed were monitor-
ing of patients for blood pressure, INR, and other parameters, 
and four public health services. Eight pharmacists suggested 
increasing the scope of the NMS to all medicines and 18 
suggested changes to the MUR service, which included 
increased GP involvement, facilitating domiciliary MURs, 
and ensuring that services are based on need. Several phar-
macists also felt that patients may not perceive benefits 
from the current services. Examples of comments are given 
in Table 5.
Awareness of MUr and nMs
Pharmacists considered that people would be more aware of 
the MUR service than the NMS: 132 (38.7%) pharmacists 
thought that at least one-half of their customers would have 
heard of the MUR, but only 16 (4.7%) felt this about the 
NMS. Actual awareness among the public was indeed low, 
with only 18.2% (182) having heard of the MUR when it 
was described to them and 8.6% (86) of the NMS. Aware-
ness of both services was significantly higher among people 
who indicated that they had experienced an MUR (52.0%; 
129 experiencing review of all medicines vs 7.1%; 53 not 
experiencing) or an NMS (29.9%; 58 in those experiencing 
vs 3.5%; 28 not experiencing). Respondents with experience 
of an MUR were also more aware of the NMS than those 
without it (18.5% 46 vs 5.1% 38). Regular medicine users 
were more aware of both the MUR (147; 24.3%) and NMS 
(62; 10.2%), compared with 9.1% (36) and 6.1% (24) in 
nonmedicine users, respectively.
Figure 1 Potential reasons for using medicines-related service identified by pharmacist and the public.
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Pharmacist versus public views of pharmacy medicines-related services
Fewer than half the pharmacists (46.3%; 155) thought 
that patients agreeing to undergo an MUR knew its purpose, 
whereas more than one-half thought that this was the case 
for the NMS (57.9%; 194).
Expectations and experiences of benefits 
from medicines-related services
Expectations of benefit from receiving medicines services 
among the public were relatively high, with overall .70% 
indicating that they would expect general benefit, that 
the pharmacist would help them know more about their 
medicines, understand how to use their medicines better, and 
encourage them to use medicines as prescribed (Table 6). 
Willingness to use both the MUR and NMS was positively 
associated with expectation of general benefit, as well as 
willingness to make an appointment and to wait longer to 
speak to the pharmacist (P,0.001). A higher proportion of 
Table 5 examples of views expressed by pharmacist and public respondents on medicine advisory services
Respondent Comment Characteristics
Pharmacist views There is little connection between prescriber/pharmacist with both 
MUr and nMs. it would be better with MUrs if patients were required 
to have them prior to a clinical review by gP and then prescriber could 
undertake their review with feedback information to hand. With the nMs 
a formal direction to enter the service should be made by prescribers and 
pharmacists should feed back to the prescribers postintervention
Male manager/sole pharmacist in 
large multiple pharmacy
MUrs and nMs are now a means for increasing pharmacy revenue, we 
are hounded daily to do MURs and NMS by head office, we are told to do 
easy ones that don’t take long, they are no longer about patient’s needs 
but how much we get for them!
Female locum in small chain pharmacy
At the moment MUr and nMs very rarely lead to optimization of 
medicine management and patients often question what was the point of it
Female manager/sole pharmacist in 
medium chain pharmacy
Public views can trust pharmacists more after these experiences. More knowledge – 
easier access for help than gP
Male, 34 or younger, on no regular 
medicines
A pharmacist has more knowledge than i thought and seems more willing 
to help and is not as patronizing as some gPs
Male, 65 or over, using more than 
eight medicines
Pharmacists do a lot more than before, they do not just dispense but they 
also make sure that i take my medication correctly and ask how i feel. 
The pharmacist also makes sure that i visit the doctor when i need to
Female, 65 or over, using up to four 
medicines
Abbreviations: gP, general practitioner; MUr, Medicine Use review; nMs, new Medicines service.
Table 6 Public and pharmacist expectations and experiences of medicines-related services
Medicines reviews with a pharmacist 
help people to:
Expectations* Experiences**
Public (%) Pharmacists (%) All public (%) Regular medicine users (%) Pharmacists (%)
Benefit in general 781 (78.2) 293 (89.3) 550 (55.3) 428 (71.2) 265 (83.9)
Know more about medicines 729 (72.9) 275 (83.1) 441 (44.2) 343 (56.8) 236 (73.8)
Understand better how to use medicines 757 (75.7) 282 (86.0) 480 (48.2) 369 (61.3) 270 (84.1)
encourage medicines use as doctor expects 774 (77.5) 230 (70.1) 515 (51.7) 396 (65.8) 185 (57.5)
sort out problems 612 (61.2) 261 (79.3) 298 (29.9) 243 (40.4) 223 (70.1)
Order fewer medicines/reduce waste 441 (44.1) 175 (53.2) 158 (15.8) 138 (22.9) 135 (42.2)
Notes: *Differences between pharmacist and public expectations were all significant (P,0.001). **Differences between pharmacist and public experiences were significant 
(P,0.001) with the exception of encouraging medicine use as per doctor expectations.
pharmacists than the public were positive about all expected 
benefits, except for increasing adherence, which was per-
ceived as an expected benefit by proportionately more of 
the public. Expectations related to sorting out problems and 
reducing the number of medicines/waste were relatively low 
in both groups.
Both groups perceived actual benefits attained to be 
lower than potential benefits, with pharmacists again being 
more likely to perceive benefits than the public, even among 
regular medicine users (Table 6).
There were 689 respondents who had experienced a ben-
efit from a pharmacy medicine service, 28.0% (193) of whom 
considered their relationship with the pharmacist changed 
as a result, 34.6% (218) felt that their view of pharmacists 
as health care professionals changed, and 35.4% (244) 
felt that their awareness of pharmacists’ knowledge about 
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In total 260 respondents provided additional comments on 
their experiences of services, 75 of whom indicated that their 
appreciation of what a pharmacist could offer had changed 
as a result (Table 5). Many respondents also indicated that 
they would use a pharmacist more readily, offering reasons 
such as ease of access and greater knowledge about medicines 
than GPs. Users of services showed increased awareness of 
pharmacists’ knowledge and potential to benefit them person-
ally, but there was also greater awareness that pharmacists 
can help with using medicines more than in the past.
Discussion
The majority of the public have received advice about medi-
cines in community pharmacies across the counter and are 
happy with this, whereas few have received advice in a pri-
vate consultation room. Both pharmacist and public surveys 
indicated that MURs are provided more often than NMS, in 
line with national statistics. The public were willing to use 
these services, although there was less willingness to allow 
telephone follow-up, an option for NMS follow-up consulta-
tions. Both pharmacists and the public reported that MURs 
after hospital discharge were infrequent, and willingness to use 
this service among the public was also low. The time taken to 
provide an MUR was estimated by pharmacists as ~10 minutes 
and NMS as 12 minutes, which align with both pharmacist 
and public perceptions of how much time people are willing 
to spend talking to a pharmacist about their medicines.
The results confirm pharmacist-driven service provi-
sion, almost all pharmacists, and nearly 70% of the public 
indicating pharmacist invitation as a reason for using 
formal services. It is concerning that over half the public 
saw wanting to help the pharmacist as another reason for 
accepting an invitation and that over half the pharmacists 
considered patients did not know the purpose of the MUR 
when they agreed to it. Awareness of both MUR and NMS 
was low among the public, even in regular medicine users, 
confirming previous qualitative work,16,17 hence the need for 
pharmacists to invite people to use services. The low uptake 
of postdischarge MURs and willingness to use this service 
has been shown previously,21 and efforts are being made to 
increase this, involving hospital pharmacists.22
Although around two-thirds of people would consider 
going to a pharmacy for advice about medicines-related 
problems, a substantial proportion prefer to talk to their 
GP, primarily due to low expectations that the pharmacist 
would be able to resolve problems. This was supported by 
infrequent experiences among the public of problems being 
resolved, in contrast to pharmacist views, most of whom 
perceived services to benefit recipients. Our data suggest that 
formal cognitive services can change peoples’ perceptions 
of pharmacists and also that using one service may increase 
awareness, thus potential use, of other services. Consulta-
tions with a pharmacist increase the likelihood of seeking 
advice again, although, as here, most people prefer to discuss 
medicines with their doctor.23
The formal services in England were developed with little 
involvement of patients or public and are aimed primarily at 
enhancing patient knowledge, understanding, and adherence 
and, for the MUR, reducing waste. Improving adherence and 
reducing waste/reordering were, however, considered by 
both groups as least likely to be achieved. Our data, which 
concur with the Australian experience,12 suggest that worries 
about side effects are among the most common concerns 
people have about medicines, thus perhaps greater emphasis 
should be placed on this aspect of medicines during consul-
tations. Relatively little research has explored what people 
really want from pharmacist-provided medicines-related 
services, most studies determine views on existing services, 
and few compare consumer and pharmacist views.24–27 As 
found here, Australian work shows low public awareness 
of medicines-related services24 and differences in views.25 
Australian pharmacists overestimated the importance of being 
available for consultations and providing advice on minor 
ailments. Our work showed that pharmacists underestimated 
the willingness of the public to both wait to speak to them and 
make appointments for services. Misunderstanding of phar-
maceutical care services between pharmacists and patients 
and divergence in perceived benefits, as well as in frequency 
of information provision, have also been found.26,27
More work is needed to determine what services are 
desired by patients and the public and how they should be 
delivered. Our study suggests that pharmacists providing 
formal services should determine the willingness of potential 
users to make appointments and make use of this to engage 
them more effectively in preparing for their consultation, 
perhaps by providing leaflets in advance. This could ensure 
that those who take up the services are those who really 
perceive a potential for benefit or have problems they wish 
to discuss with a pharmacist and thus may lead to increased 
user experiences of benefits.
strengths and limitations
Both surveys were developed from the findings of qualita-
tive work, however no psychometric testing was carried out. 
Both achieved relatively good response rates in comparison 
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pharmacist survey required two reminders. The surveys were 
administered in the same area of England at the same time 
and the respondents were reasonably representative of their 
respective populations. Equivalent questions were used to 
enable comparisons between pharmacists and public. Data on 
service provision, obtained to assess sample representative-
ness, were self-reported. Both surveys may be subjected to 
recall bias and in addition, the public survey was interviewer-
assisted, so may include an element of obsequiousness bias.
Conclusion
The public is willing to use community pharmacy medicines-
related services, but many people prefer to discuss problems 
with a doctor. Perceptions of pharmacists and the public 
differed with respect to reasons for using services, willing-
ness to wait to see a pharmacist and to make appointments, 
as well as expected and perceived benefits of services. For 
services to improve, the pharmacy profession needs a better 
awareness of what the public, especially those with potential 
to benefit from services, view as acceptable and desirable. 
Professional pharmacy organizations and pharmacists them-
selves also need to make use of these findings to encourage 
greater uptake of services through promotion and explanation 
of their potential benefits.
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